.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Merck
McKinsey
Fish and Richardson
Mallinckrodt
Baxter
Medtronic
Moodys
UBS

Generated: November 19, 2017

DrugPatentWatch Database Preview

Rofecoxib - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rofecoxib and what is the scope of rofecoxib freedom to operate?

Rofecoxib
is the generic ingredient in one branded drug marketed by Merck and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Rofecoxib has thirty-seven patent family members in thirty-one countries.

There are two drug master file entries for rofecoxib.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-001May 20, 1999DISCNNoNo► Subscribe► SubscribeY► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-002May 20, 1999DISCNNoNo► Subscribe► SubscribeY► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-003Feb 25, 2000DISCNNoNo► Subscribe► SubscribeY► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-001May 20, 1999DISCNNoNo► Subscribe► SubscribeY► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 1999DISCNNoNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: rofecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-002May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-001May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-001May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-001May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-003Feb 25, 2000► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
TABLET;ORAL021042-003Feb 25, 2000► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-002May 20, 1999► Subscribe► Subscribe
Merck
VIOXX
rofecoxib
SUSPENSION;ORAL021052-001May 20, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: rofecoxib

Country Document Number Estimated Expiration
Estonia03746► Subscribe
South Africa9704206► Subscribe
Slovakia156798► Subscribe
Algeria2200► Subscribe
United Kingdom9612063► Subscribe
China1140267► Subscribe
Argentina012014► Subscribe
Poland329940► Subscribe
New Zealand332670► Subscribe
Iceland4891► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Fish and Richardson
Cipla
Novartis
Federal Trade Commission
Medtronic
Harvard Business School
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot